Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Improvements in blood sugar and cardiovascular risk also declined once the therapy ended
10.1042/BST20200270 Summary Keywords GLP-1, immunemetabolic signaling, metabolic disease, neuroendocrine peptides, orphan receptors, peptide therapeutics, polypharmacology Citation Niazi SK (2026) Beyond GLP-1: underexplored peptidereceptor systems as the next frontier in drug discovery
S2CID 4978703
Their use as a treatment for obesity, often off-label, has gained a lot of attention in recent years
US$ 27.72
US$ 25.96
US$ 25.62
.webp)
US$ 27.85
US$ 27.22
US$ 20.84
US$ 24.58
US$ 22.17
US$ 29.48
US$ 23.60
